Skip to main content
Equibles

Velan Capital Investment Management LP

Position in VRCA — Verrica Pharmaceuticals Inc.

CIK 1848809 ALPHARETTA, GA
Back to VRCA Full portfolio

Position in VRCA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,885,941
+$391,394 QoQ
Shares Held
471,559
0.0% QoQ
Ownership
2.75%
of shares outstanding
% of Portfolio
1.77%
of 13F equity value
Holder Rank
#4
of 43 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRCA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Velan Capital Investment Management LP holds $153,684,284 across 45 Biotechnology names. VRCA ranks #14 (1.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PRAX
Praxis Precision Medicines, Inc.
 88,781 $29,722,990
2 MPLT
MapLight Therapeutics, Inc.
 492,893 $17,665,285
3 STRO
Sutro Biopharma, Inc.
 512,160 $17,003,712
4 IMMX
Immix Biopharma, Inc.
 1,085,000 $11,186,350
5 TARA
Protara Therapeutics, Inc.
 2,844,652 $10,866,570
6 ABVX
Abivax S.A.
 65,630 $8,745,853
7 TENX
Tenax Therapeutics, Inc.
 549,985 $8,002,281
8 EDSA
Edesa Biotech, Inc.
 827,500 $6,727,575

All Filings in VRCA

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,885,941 471,559
2026-03-31 $2,494,547 471,559
2025-12-31 $3,918,655 471,559